The global ECG telemetry devices market size was estimated to be USD 6.11 billion in 2023 and is expected to reach at USD 12.78 billion by 2034 with a CAGR of 6.94% during the forecast period 2024-2034. Increasing prevalence of cardiovascular diseases, growing focus on developments in the telecommunication infrastructure, rising geriatric population, surge in technological advancements in remote monitoring technologies, increasing commercialization of new ECG telemetric devices, growing need for telemetry equipment that are small & precise, rising demand for homecare monitoring systems, and surge in launch of next-generation ECG platforms are some of the key factors boosting the market growth.
Surge in launch of next-generation ECG platforms is predicted to boost the market growth during the forecast period. Through ECG telemetry technology, patients can be monitored from the comfort of their homes, thus eliminating the expense associated with unnecessary hospitalization. These systems incorporate reminders and adherence tracking features, simplifying the process of self-monitoring heart rhythms for patients, particularly crucial post-surgery. For instance, in April 2022, B-Secur has introduced an advanced ECG cloud-based platform suitable for Holter monitors, wearables, and implanted devices. As stated in a company announcement, the cloud-based system (HeartKey 2.0) minimizes signal interference in ECG, enhancing the accuracy of ECG analysis for medical professionals and supporting the shift towards remote heart monitoring.
By product, implantable loop recorder was the highest revenue-grossing segment in the global ECG telemetry devices market in 2023 owing to rising prevalence of cardiac disorders, increasing technological advancements in cardiac monitoring devices, growing demand for remote patient monitoring, and surge in acquisitions of the market players. Additionally, event monitoring and mobile cardiac telemetry is predicted to grow at fastest CAGR during the forecast period owing to the surge in technological advancements, rising approvals of advanced monitoring devices, and increasing introduction of new mobile cardiac telemetry systems. For instance, in April 2022, Biotricity has commenced the official commercial distribution of its FDA-approved wireless wearable cardiac monitoring device, known as Biotres. The product has been open for pre-order to medical professionals, healthcare facilities, and individuals since February 2022.
By application, arrhythmias was the highest revenue-grossing segment in the global ECG telemetry devices market in 2023 owing to the increasing prevalence of arrhythmias, growing geriatric population, rising demand for diagnostic tools for arrhythmias, and surge in launch of innovative products. For instance, in February 2022, AliveCor has introduced the KardiaMobile Card, an ultra-slim and highly convenient personal ECG device. Resembling the dimensions of a regular credit card, the KardiaMobile Card can effortlessly slide into any wallet and provides a medically precise single-lead ECG within half a minute. Additionally, myocardial ischemia & infraction is predicted to grow at fastest CAGR during the forecast period owing to the rising prevalence of heart attack, increasing research & development activities, and growing regulatory approvals.
By end-user, hospitals was the highest revenue-grossing segment in the global ECG telemetry devices market in 2023 owing to the surge in prevalence of cardiovascular disorders, growing number of cardiac surgeries performed within hospitals, and rising adoption of advanced technologies. Additionally, home healthcare is predicted to grow at fastest CAGR during the forecast period owing to the growing need for telemetry equipment that are small, precise & reliable homecare monitoring and increasing launch of advanced products. For instance, in January 2022, Philips has unveiled the initial integrated 12-lead ECG solution for decentralized clinical trials that can be used at home.
North America region is anticipated for the highest revenue share during the forecast period owing to the increasing prevalence of cardiovascular disorders, growing demand for ECG telemetry devices, surge in technological advancements in patient monitoring devices, rising launch of advanced products, and increasing approvals by regulatory bodies. For instance, in March 2022, The electrocardiogram (EKG) app for heart monitoring on Fitbit's latest Sense smartwatch received approval from the US Food and Drug Administration (FDA). Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the growing prevalence of heart attacks, rising healthcare expenditure, increasing demand for ECG telemetric devices, and surge in introduction of innovative products. For instance, in August 2022, SmartCardia has introduced the 7L patch, a cardiac monitoring patch equipped with seven leads. This innovative technology merges wearable medical advancements with AI to deliver predictive and personalized patient insights through remote monitoring in India. The SmartCardia patch measures a comprehensive range of parameters, including seven-lead electrocardiograms (ECG), heart rate, pulse rate, respiration rate, oxygen saturation (SpO2), skin temperature, activity, and posture. All of these measurements are obtained from a single compact unit with clinical precision.
Surge in launch of next-generation ECG platforms is predicted to boost the market growth during the forecast period. Through ECG telemetry technology, patients can be monitored from the comfort of their homes, thus eliminating the expense associated with unnecessary hospitalization. These systems incorporate reminders and adherence tracking features, simplifying the process of self-monitoring heart rhythms for patients, particularly crucial post-surgery. For instance, in April 2022, B-Secur has introduced an advanced ECG cloud-based platform suitable for Holter monitors, wearables, and implanted devices. As stated in a company announcement, the cloud-based system (HeartKey 2.0) minimizes signal interference in ECG, enhancing the accuracy of ECG analysis for medical professionals and supporting the shift towards remote heart monitoring.
By product, implantable loop recorder was the highest revenue-grossing segment in the global ECG telemetry devices market in 2023 owing to rising prevalence of cardiac disorders, increasing technological advancements in cardiac monitoring devices, growing demand for remote patient monitoring, and surge in acquisitions of the market players. Additionally, event monitoring and mobile cardiac telemetry is predicted to grow at fastest CAGR during the forecast period owing to the surge in technological advancements, rising approvals of advanced monitoring devices, and increasing introduction of new mobile cardiac telemetry systems. For instance, in April 2022, Biotricity has commenced the official commercial distribution of its FDA-approved wireless wearable cardiac monitoring device, known as Biotres. The product has been open for pre-order to medical professionals, healthcare facilities, and individuals since February 2022.
By application, arrhythmias was the highest revenue-grossing segment in the global ECG telemetry devices market in 2023 owing to the increasing prevalence of arrhythmias, growing geriatric population, rising demand for diagnostic tools for arrhythmias, and surge in launch of innovative products. For instance, in February 2022, AliveCor has introduced the KardiaMobile Card, an ultra-slim and highly convenient personal ECG device. Resembling the dimensions of a regular credit card, the KardiaMobile Card can effortlessly slide into any wallet and provides a medically precise single-lead ECG within half a minute. Additionally, myocardial ischemia & infraction is predicted to grow at fastest CAGR during the forecast period owing to the rising prevalence of heart attack, increasing research & development activities, and growing regulatory approvals.
By end-user, hospitals was the highest revenue-grossing segment in the global ECG telemetry devices market in 2023 owing to the surge in prevalence of cardiovascular disorders, growing number of cardiac surgeries performed within hospitals, and rising adoption of advanced technologies. Additionally, home healthcare is predicted to grow at fastest CAGR during the forecast period owing to the growing need for telemetry equipment that are small, precise & reliable homecare monitoring and increasing launch of advanced products. For instance, in January 2022, Philips has unveiled the initial integrated 12-lead ECG solution for decentralized clinical trials that can be used at home.
North America region is anticipated for the highest revenue share during the forecast period owing to the increasing prevalence of cardiovascular disorders, growing demand for ECG telemetry devices, surge in technological advancements in patient monitoring devices, rising launch of advanced products, and increasing approvals by regulatory bodies. For instance, in March 2022, The electrocardiogram (EKG) app for heart monitoring on Fitbit's latest Sense smartwatch received approval from the US Food and Drug Administration (FDA). Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the growing prevalence of heart attacks, rising healthcare expenditure, increasing demand for ECG telemetric devices, and surge in introduction of innovative products. For instance, in August 2022, SmartCardia has introduced the 7L patch, a cardiac monitoring patch equipped with seven leads. This innovative technology merges wearable medical advancements with AI to deliver predictive and personalized patient insights through remote monitoring in India. The SmartCardia patch measures a comprehensive range of parameters, including seven-lead electrocardiograms (ECG), heart rate, pulse rate, respiration rate, oxygen saturation (SpO2), skin temperature, activity, and posture. All of these measurements are obtained from a single compact unit with clinical precision.
Segmentation: ECG Telemetry Devices Market Report 2022 - 2033
ECG Telemetry Devices Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
- Implantable Loop Recorders
- Event Monitoring and Mobile Cardiac Telemetry
- Others
ECG Telemetry Devices Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- Arrhythmias
- Myocardial Ischemia & Infraction
- Pacemaker Monitoring
- Others
ECG Telemetry Devices Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Home Healthcare
- Hospitals
ECG Telemetry Devices Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. ECG Telemetry Devices Market: Product Estimates & Trend Analysis
8. ECG Telemetry Devices Market: Application Estimates & Trend Analysis
9. ECG Telemetry Devices Market: End-user Estimates & Trend Analysis
10. Regional Market Analysis
11. North America ECG Telemetry Devices Market
12. Europe Global ECG Telemetry Devices Market
13. Asia Pacific Global ECG Telemetry Devices Market
14. Latin America Global ECG Telemetry Devices Market
15. MEA Global ECG Telemetry Devices Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Boston Scientific Corporation
- BioTelemetry Inc.
- Medtronic Inc.
- Hill-Rom Services Inc. (Welch Allyn)
- iRhythm Technologies Inc.
- Aerotel Medical Systems Ltd
- Preventice Solutions Inc.
- GE Healthcare
- Philips Healthcare
- Medicalgorithmics SA
- Nihon Kohden Corporation
- BIOTRONIK
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 145 |
| Published | October 2023 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 6.11 Billion |
| Forecasted Market Value ( USD | $ 12.78 Billion |
| Compound Annual Growth Rate | 6.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
